When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don’t fight them — throw them in the cellular trash. In a new study, ...

Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with ...

Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with each other.

Researchers at Linköping University show how two important cancer-related proteins can be prevented from collaborating with ...

Please provide your email address to receive an email when new articles are posted on . Inhibiting RMB42 disrupted production of Myc proteins in pancreatic cancer cells. This approach could curtail ...

The growth protein, MYC, was consistently found with RBM42, which spurs MYC production, in human pancreatic tumors. Above, microscopy for MYC (red) and RBM42 (green) in a representative pancreatic ...

Cancer cells are characterized by their aggressiveness: they grow rapidly and spread to other parts of the body. To enable this, numerous mechanisms come into play, and one of them involves a protein ...

Certain cancer-driving proteins resist nearly all existing treatments, making many aggressive cancers effectively untreatable. Researchers devised a strategy to use protein-like polymers called ...

For decades, scientists have tried to stop cancer by disabling the mutated proteins that are found in tumors. But many cancers manage to overcome this and continue growing. Now, scientists think they ...